VivoSeq
Other

Pathological Gambling

11

Pipeline Programs↗

0

Active Trials↗

5

Companies Involved↗

Pathological Gambling is an emerging landscape with 11 programs across 5 companies. The most active players are Eli Lilly, Purdue Pharma LP, Glaxo Dba Glaxosmithkline. 2 therapies are approved with 3 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

37/100

Pipeline Velocity

0/100

Mech. Concentration

14/100

Completion Rate

92/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

Phase 2P

Purdue Pharma LP

1 program

Phase 3G

Glaxo Dba Glaxosmithkline

1 program

PreclinicalTeva logo

Teva

1 program

PreclinicalS

Somaxon Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

13

clinical trials

Completed11 · 85%
Terminated1 · 8%
Unknown1 · 8%

Clinical Trials

Trial Activity

13 trials

Tolcapone Treatment of Pathological Gambling
Completed·UUniversity of Chicago·Phase 2·NCT00927563·24 enrolled
Bupropion in the Treatment of Pathological Gambling
Completed·UUniversity of Iowa·N/A·NCT00055393·80 enrolled
Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention
Completed·FFinnish Institute for Health and Welfare·Phase 4·NCT01528007·100 enrolled
Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
Completed·CCentre for Addiction and Mental Health·N/A·NCT00326807·50 enrolled
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
Completed·UUniversity of Minnesota·Phase 1·NCT00273702·36 enrolled
Investigation of Naltrexone for Pathological Gambling
Completed·YYale University·Phase 2·NCT01057862·9 enrolled
Memantine Treatment Study of Pathological Gambling
Completed·YYale University·Phase 2·NCT00585169·29 enrolled
Acamprosate in the Treatment of Pathological Gambling
Completed·UUniversity of Iowa·Phase 4·NCT00571103·26 enrolled
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
Completed·SSomaxon Pharmaceuticals·Phase 2/3·NCT00132119·233 enrolled
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
Completed·LLindner Center of HOPE·Phase 3·NCT00438776·42 enrolled
Silymarin Treatment of Pathological Gambling: A Double-Blind, Placebo-Controlled Study
Completed·UUniversity of Chicago·Phase 2·NCT02337634·55 enrolled
Topiramate in the Treatment of Pathological Gambling
Terminated·IIcahn School of Medicine at Mount Sinai·Phase 3·NCT00245583·42 enrolled
Descriptive Study of a French Sample of "at Risk" and Pathological Gamblers Followed in a French Structure Specialised in Addictive Disorders.
Unknown·NNantes University Hospital·N/A·NCT00360321

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)